P. Murali Doraiswamy | |
|---|---|
| Nationality | Indian |
| Alma mater | University of Madras |
| Known for | Neurocognitive disorders, Artificial intelligence in psychiatry, Alzheimer's research |
| Notable work | The Alzheimer's Action Plan |
| Awards | Fellow of the Royal College of Physicians (London), Fellow of the American Neurological Association |
| Scientific career | |
| Fields | Psychiatry, Neuroscience, Precision medicine |
| Institutions | Duke University School of Medicine |
Murali Doraiswamy is a physician-scientist, psychiatrist, and professor at Duke University School of Medicine. [1] He is a leading expert in the fields of neurocognitive disorders, brain aging, and precision medicine. [2] Doraiswamy is widely recognized for his research on Alzheimer's disease, psychiatric disorders, and the applications of artificial intelligence in mental health care. [3] He has authored over 400 publications and co-authored the book The Alzheimer's Action Plan . [4]
Doraiswamy earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) degree from the University of Madras, India. After completing his medical education, he pursued residency training in Psychiatry before joining Duke University, where he has built a distinguished career in neuroscience and clinical research.
Doraiswamy serves as a Professor in the Departments of Psychiatry and Medicine at Duke University School of Medicine. He is also the Director of the Neurocognitive Disorders Program and holds affiliations with the Duke Center for Applied Genomics and Precision Medicine, the Duke Institute for Brain Sciences, and the Duke Initiative for Science & Society. [5]
His research centers on neurocognitive disorders, Brain health, and the role of artificial intelligence in Psychiatry. At Duke University, he leads a clinical trials unit that has contributed to the development of diagnostic tests, digital biomarkers, and treatments for neurodegenerative conditions. His work has had a major impact on Alzheimer's disease research, depression, and cognitive resilience in aging. [3]
Doraiswamy has also served as an advisor to major institutions, including the National Institutes of Health (NIH), [6] the Food and Drug Administration (FDA), [7] the World Health Organization (WHO), and the World Economic Forum (WEF). [8] He has chaired global panels on Brain research and innovation in mental health care. [9]
Doraiswamy's research has been featured in major media outlets, including The New York Times , TIME Magazine , [12] Scientific American , [13] The Wall Street Journal , [14] and BBC News . [15] He has appeared on television programs such as CBS Evening News , [16] NPR, [17] and The Dr. Oz Show . He was also featured in the documentaries (Dis)Honesty: The Truth about Lies [18] and Mysteries of the Brain . [19]